By End User / Care Setting

Ambulatory Care / Specialty Infusion Centers Market Analysis

Cross-industry research covering Ambulatory Care / Specialty Infusion Centers across 1 market reportspanning Pharmaceuticals.

1 Reports

1 Industries

Reports Covering Ambulatory Care / Specialty Infusion Centers

Dysautonomia Treatment Drugs Market to Reach USD 8.4 Billion by 2033 at 7.2% CAGR

Pharmaceuticals·Market: USD 4.8 Billion (2025)·CAGR: 7.2%

IV saline and IVIG for post-COVID POTS are predominantly administered in ambulatory infusion settings billed under Medicare Part B; this site of care is the fastest-growing channel for dysautonomia pharmacotherapy as post-COVID case volumes outpace inpatient capacity.

18%

Market Share

9.2%

Segment CAGR

Explore More Segments

Browse all market segments across our research coverage.

View all segments